Clinical Trials Browser

Phase 2 × Unknown × Rectal Neoplasms × Clear all

NCT03992456 2024-05-21

Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer

Phase 2 Unknown

12 enrolled 16 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT04543695 2024-03-26

A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT03951337 2024-03-12

64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum)

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT06239870 2024-02-02

ESTIMATE

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT03729687 2023-11-30

LARCT-US

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT05307198 2023-10-10

RAIC

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT04083365 2023-05-31

PANDORA

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT05868317 2023-05-22

Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT05858567 2023-05-15

RECMULRA-TNT

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT05420584 2023-05-11

NECI

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT05815303 2023-04-18

XELOX Combined With Cadonilimab Versus XELOX as Neoadjuvant Treatment for Locally Advanced, pMMR Rectal Cancer

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT03038256 2023-03-22

EXPLORE

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT05763927 2023-03-10

Neoadjuvant Therapy for Locally Advanced Rectal Cancer With Fruquintinib, Toripalimab and SRT

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT05640726 2022-12-07

The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT04688242 2022-12-06

PILLARS

Phase 2 Unknown

Gastrointestinal

Low Anterior Resection Syndrome, Rectal Neoplasms

NCT05575635 2022-10-12

Neoadjuvant Treatment of Fruquintinib Combined With Concurrent Chemoradiotherapy for LARC

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT01871571 2022-08-09

Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT05241574 2022-02-15

Planned Non-operative Management for Rectal Cancer

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT04293419 2021-06-21

DUREC

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT04664504 2021-06-08

A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT03484221 2021-04-14

Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT04801511 2021-03-17

CORT

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT04749381 2021-02-11

RCT

Phase 2 Unknown

Gastrointestinal

Patient Compliance, Rectal Neoplasms

NCT04674696 2020-12-19

SHORT-ICAR

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT04621370 2020-11-09

PRIME-RT

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT04340401 2020-07-09

Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT02887313 2020-05-04

FOTAC

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT02161822 2020-03-25

Capecitabine Plus Simvastatin in Locally Advanced Rectal Cancer Patients

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT04296240 2020-03-05

Induction Chemotherapy for MRF-negative, Moderate-risk, Resectable Middle and Low Rectal Cancer

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT03022734 2020-01-13

Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis

Phase 2 Unknown

Gastrointestinal

Neoplasm Metastasis, Rectal Neoplasms

NCT01923987 2019-09-20

Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT01047969 2019-06-13

Avoiding Surgery in Rectal Cancer After Pre-Operative Therapy

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT03040180 2019-01-25

nECT

Phase 2 Unknown

Gastrointestinal

Neoplasms, Neoplastic Processes, Pathologic Processes, Rectal Neoplasms, Colorectal Neoplasms

NCT01037049 2018-09-17

Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma, Carcinoma, Adenocarcinoma, Mucinous, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms, Neoplasms, Cystic, Mucinous, and Serous

NCT02919878 2018-08-13

Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal Cancer

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT03561142 2018-06-19

CAO/ARO/AIO-16

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT03422835 2018-02-06

Robotic Assisted Transanal Total Mesorectal Excision Surgery for Rectal Cancer in Low Site

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT02942563 2018-01-03

Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT01431599 2017-10-10

KROG 11-02

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT03280407 2017-09-28

NEOLAR

Phase 2 Unknown

Gastrointestinal

Intestinal Diseases, Intestinal Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01952951 2017-09-13

PREPARE

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma, Rectal Neoplasms

NCT02941562 2016-10-24

A Prospective Phase II Randomized Clinical Trial of Preoperative Chemotherapy Combined With Short-course Radiotherapy Versus Conventional Neo-adjuvant Therapy for Locally Advanced Rectal Cancer Implemented by MDT

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT02830633 2016-07-13

Trial to Evaluate Laparoscopy-assisted Nerve-preserved Total Mesorectal Excision (LNTME) Versus Open TME for Rectal Cancer

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT02603302 2016-06-14

RaDE

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT01257360 2016-01-13

NEO-RIT

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT01930942 2016-01-05

Genetic Profile on Predicting Sensibility of Preoperative Chemoradiotherapy on Locally Advanced Rectal Carcinoma

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT02510378 2015-07-29

Short Course Radiotherapy Combined With Chemotherapy in Stage IV Rectal Cancer With Resectable Liver Metastases

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT02490709 2015-07-07

Local Excision of Clinical T3 Rectal Adenocarcinoma Showing Major Response(ycT0-1) After Neoadjuvant Chemoradiotherapy

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT02488707 2015-07-02

MISS-TRICR

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT01818973 2015-06-08

Preoporative Bevacizumab, Radiation Therapy, and XELOX Chemotherapy for Locally Advanced Nonmetastatic Rectal Cancer

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms